The results showed that at the initial stage of infection, the expression levels of intestinal inflammatory factors such as IL-1β, IL-6, IL-10, TGF-β and TNF-α in the treatment group were much lower than those in the challenge group (p < 0.01). Here, TGFB1 is linked to infection.